Insider Transactions in Q3 2021 at Evolus, Inc. (EOLS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2021
|
Alphaeon 1 LLC |
SELL
Open market or private sale
|
Direct |
2,597,475
-29.99%
|
$23,377,275
$9.5 P/Share
|
|
Aug 27
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
51,000
+0.68%
|
$510,000
$10.93 P/Share
|
|
Aug 26
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
66,000
+0.88%
|
$726,000
$11.02 P/Share
|
|
Aug 25
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
44,000
+0.6%
|
$484,000
$11.12 P/Share
|
|
Aug 24
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
72,219
+0.98%
|
$794,409
$11.17 P/Share
|
|
Aug 23
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
69,781
+0.96%
|
$767,591
$11.03 P/Share
|
|
Aug 23
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
26,077
-2.23%
|
$286,847
$11.0 P/Share
|
|
Aug 20
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
48,000
+0.67%
|
$480,000
$10.56 P/Share
|
|
Aug 20
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
49,878
-4.09%
|
$498,780
$10.61 P/Share
|
|
Aug 19
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
55,000
+0.77%
|
$550,000
$10.51 P/Share
|
|
Aug 19
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
11,962
-0.97%
|
$119,620
$10.5 P/Share
|
|
Aug 18
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
45,000
+0.63%
|
$450,000
$10.54 P/Share
|
|
Aug 18
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
25,000
-1.99%
|
$250,000
$10.44 P/Share
|
|
Aug 17
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
70,000
+0.99%
|
$700,000
$10.69 P/Share
|
|
Aug 17
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
42,083
-3.24%
|
$420,830
$10.06 P/Share
|
|
Aug 16
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
65,000
+0.93%
|
$715,000
$11.34 P/Share
|
|
Aug 16
2021
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
47,737
-11.24%
|
$525,107
$11.35 P/Share
|
|
Aug 13
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Indirect |
14,043
+0.19%
|
$154,473
$11.11 P/Share
|
|
Aug 13
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
49,714
+0.72%
|
$497,140
$10.98 P/Share
|
|
Aug 13
2021
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
22,708
-5.07%
|
$227,080
$10.66 P/Share
|
|
Aug 12
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Indirect |
23,000
+0.31%
|
$230,000
$10.99 P/Share
|
|
Aug 12
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
39,126
+0.57%
|
$391,260
$10.93 P/Share
|
|
Aug 11
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
26,160
+0.38%
|
$261,600
$10.77 P/Share
|
|
Aug 10
2021
|
David Moatazedi Director |
BUY
Open market or private sale
|
Direct |
41,763
+7.29%
|
$459,393
$11.18 P/Share
|
|
Aug 10
2021
|
Crystal Muilenburg Chief Marketing Officer |
BUY
Open market or private sale
|
Direct |
5,362
+5.02%
|
$58,982
$11.18 P/Share
|
|
Aug 10
2021
|
Rui Avelar Officer |
SELL
Open market or private sale
|
Direct |
14,293
-6.38%
|
$157,223
$11.18 P/Share
|
|
Aug 10
2021
|
Lauren P Silvernail Officer |
BUY
Open market or private sale
|
Direct |
14,293
+6.83%
|
$157,223
$11.18 P/Share
|